TSS
BRNS

Two Sigma Securities’s Barinthus Biotherapeutics BRNS Stock Holding History

Two Sigma Securities’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.29K Buy
+11,052
New +$7.2K ﹤0.01% 1574
2023
Q1 		– Sell
-16,919
Closed -$39.8K – 2682
2022
Q4 		$39.8K Buy
+16,919
New +$43.1K ﹤0.01% 2194

Other funds holding BRNS

MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
GP
GLR Partners Columbia, Maryland $215M AUM
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.5B AUM 13.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Two Sigma Securities's BRNS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Barinthus Biotherapeutics (BRNS) in Q2 2026: 11,052 shares worth $7.29K. The stake represents ﹤0.01% of the portfolio and ranks #1574 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in BRNS as recently as Q4 2022.

Two Sigma Securities first reported a position in BRNS in Q4 2022 and has held it in 2 quarters since. The position peaked at $39.8K in Q4 2022. 15 funds tracked by Wall St. Rank hold BRNS as of Q2 2026.

  • Two Sigma Securities held 11,052 shares of Barinthus Biotherapeutics worth $7.29K as of Q2 2026.
  • Barinthus Biotherapeutics was a new Two Sigma Securities position in Q2 2026.
  • Barinthus Biotherapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1574 holding.
  • Two Sigma Securities first reported a position in Barinthus Biotherapeutics in Q4 2022 and has held it in 2 quarters since.
  • Two Sigma Securities's Barinthus Biotherapeutics position peaked at $39.8K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.